Couldn`t PTSC drain TPL? I could work the otherway too PTSC making sales on thier own, loaning TPL cash and then holding TPL`s interest in the IP as collateral?

Just remember, PTSC is creating expenses of their own - cost of sales (well, perhaps ``cost of prospects``).

Perhaps I don`t understand the concept behind the construction of P-NEWCO, but I would expect that to be the places where the debits and credits take place. Neutral territory, shared risk. I think there`s just as much pressure on PTSC to close Ignite/inflame sales as there is on TPL to drive the litigation issue. The neat thing is that i don`t think PTSC has to share the revenues from their own sales, but TPL has to from IP licensing.

I won`t go as far as to say it`s a level playing field outside of that, I just don`t know.

Please explain in detail how you could see license revenues taking up to 3 quarters to hit the books...

regards